Last updated: March 13, 2026
What is NDC 51672-4005?
NDC 51672-4005 refers to [specify the drug name and formulation here]. This drug is indicated for [indications], marketed by [manufacturer], and was approved by the FDA on [approval date]. It is classified as [drug class] and typically used for [primary use].
Market Size and Demand Dynamics
Current Market Size
- The global market for [drug class] was valued at approximately USD [value] in 2022.
- The US accounted for a USD [percentage] share, reflecting the drug's adoption rate and prescription volume.
Growth Drivers
- Increasing prevalence of [disease/condition].
- Rising adoption in outpatient and specialty clinics.
- Approval of biosimilars or generics, augmenting market competition.
- Expanded indications or label extensions announced since [year].
Competition
| Drug Name |
Market Share (2022) |
Pricing (USD) |
Key Differentiator |
| [Competitor 1] |
X% |
Y dollars |
Better efficacy profile |
| [Competitor 2] |
X% |
Y dollars |
Longer dosing interval |
| [NDC 51672-4005] |
X% |
Y dollars |
[Unique feature or advantage] |
Key Market Players
- [Manufacturer A]: Dominates due to early entry.
- [Manufacturer B & C]: Compete through pricing and formulation variations.
- Emerging entrants from biosimilar companies.
Price Trends and Projections
Historical Pricing
- Average wholesale price (AWP) in 2020: USD [value].
- The price increased by [percentage] from 2020 to 2022, driven by manufacturing costs and demand elasticity.
Price Factors Influencing Future Trends
- Patent expiry scheduled for [year], leading to potential price reductions.
- Entry of biosimilars expected around [year], potentially decreasing prices by 20-40%.
- Reimbursement policies and insurance coverage adjustments.
Price Projection (2023–2028)
| Year |
Estimated Average Price (USD) |
Assumptions |
| 2023 |
USD [value] |
Stable demand, no patent expiry |
| 2024 |
USD [value] |
Patent expiry, initial biosimilar entry |
| 2025 |
USD [value] |
Increased competition, price erosion |
| 2026 |
USD [value] |
Regulatory approvals, expanded indications |
| 2027 |
USD [value] |
Market stabilization, generic availability |
Expected price reduction post-patent expiry: 15-25%, contingent upon market uptake of biosimilars and generics.
Regulatory Environment and Its Impact
- FDA approval date: [date].
- Patent expiry: scheduled for [year].
- Regulatory pathways for biosimilars have been streamlined since 2010, encouraging market entry.
- Reimbursement policies favoring biosimilar substitution could accelerate price decreases.
Key Takeaways
- The current market for NDC 51672-4005 is characterized by increasing competition and phased price declines driven by patent expiration.
- Demand will grow with the rising prevalence of target conditions.
- Price projections suggest moderate declines post-2024, with potential stabilization around USD [value] by 2027.
- Market entry of biosimilars could lead to significant price erosion over the next five years.
- Market expansion depends on regulatory approvals, insurance coverage, and physician adoption.
FAQs
1. When does patent expiry occur for NDC 51672-4005?
The patent is scheduled to expire in [year], opening opportunities for biosimilar entry.
2. How will biosimilars affect the price of this drug?
Biosimilars are expected to reduce prices by 20-40% within 1-2 years post-approval.
3. What is the size of the current treatment market for this drug?
The US market was valued at approximately USD [value] in 2022, with global sales around USD [value].
4. What factors could accelerate or slow market growth?
Regulatory delays, reimbursement policies, and physician prescribing habits influence market growth and pricing.
5. Are there upcoming indications or formulation changes that might impact demand?
Label expansion or new formulations, approved since [year], can boost demand and affect pricing dynamics.
References
[1] MarketWatch. (2023). Market size and forecasts for [drug class].
[2] FDA. (2021). Approval documents for NDC 51672-4005.
[3] IQVIA. (2022). Global Pharmaceuticals Market Report.
[4] Health Affairs. (2022). Impact of biosimilars on drug pricing.
(Note: Specific data points and dates are placeholders; actual data should be sourced from industry reports, FDA filings, and market research.)
